Where to buy cheaper Quizartinib and buying advice
Quizartinib is a targeted drug used to treat acute myeloid leukemia (AML). It has not yet been officially approved for marketing in China, so domestic patients cannot purchase it directly through formal channels. If patients need to use quizartinib, they can only purchase it through formal overseas channels. This situation has led to a lack of domestic drug supply, and also requires patients to carefully choose purchasing channels to ensure drug safety.
In foreign markets, Quizartinib has both the original drug version and generic versions produced in multiple countries. The price of original drugs is relatively high, usually tens of thousands of yuan per box, which prohibits many patients. In contrast, the generic version produced by Lucius Pharmaceutical Factory in Laos is more affordable, with specifications including 17.7mg14 tablets and 26.5mg14 tablets. The price is about more than one thousand yuan, which greatly reduces the financial burden of patients.

When patients choose to purchase Quizartinib, they should give priority to regular and qualified overseas drug suppliers and avoid purchasing counterfeit and substandard drugs through unknown channels. It is recommended to purchase through legal medical institutions or regulated overseas pharmacies, and keep relevant purchase receipts for future tracking of medication effects and safety. In addition, patients should use it under the guidance of their attending physician and closely monitor the efficacy and possible adverse reactions.
With the continuous improvement of China's drug regulatory policies and the acceleration of the introduction of new drugs, Quizartinib is expected to obtain domestic marketing approval in the future. By then, patients can purchase it through formal channels in local medical institutions and enjoy a more convenient and safer medication environment. Prior to this, patients and their families need to carefully evaluate their own situation, choose purchasing channels reasonably, and cooperate with doctors to manage the entire process to ensure treatment effects and medication safety.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)